目的:本研究旨在评估嗜酸性粒细胞增多性肺疾病(EGPA)患者的护理需求,并探讨个性化护理计划在改善患者肺功能、神经功能和生活质量方面的有效性。方法:2023年6月至2024年8月,采用随机数表法选取70名EGPA患者,随机分为观察组和对照组,每...目的:本研究旨在评估嗜酸性粒细胞增多性肺疾病(EGPA)患者的护理需求,并探讨个性化护理计划在改善患者肺功能、神经功能和生活质量方面的有效性。方法:2023年6月至2024年8月,采用随机数表法选取70名EGPA患者,随机分为观察组和对照组,每组35名。观察组实施个性化护理计划,包括多学科团队合作、药物管理、心理支持和健康教育等。对照组接受标准护理。对两组患者的肺功能(FEV1、FVC)、神经功能(NIHSS评分)和生活质量(SGRQ评分)进行评估。结果:观察组在干预后的FEV1、FVC、NIHSS评分和SGRQ评分均有显著改善,与对照组相比差异具有统计学意义(P Objective: This study was designed to assess the care needs of patients with eosinophilic lung disease (EGPA) and to explore the effectiveness of personalized care plans in improving lung function, neurological function, and quality of life in patients. Methods: From June 2023 to August 2024, 70 EGPA patients were selected by random number table method and randomly divided into observation group and control group, with 35 patients in each group. The observation group implemented individualized care plan, including multidisciplinary teamwork, medication management, psychological support and health education. The control group received standard care. Pulmonary function (FEV1, FVC), neurological function (NIHSS score), and quality of life (SGRQ score) were evaluated in both groups. Results: FEV1, FVC, NIHSS and SGRQ scores in the observation group were significantly improved after intervention, and the difference was statistically significant compared with the control group (P < 0.05). Conclusion: Personalized nursing plan can effectively improve lung function, neurological function and quality of life of EGPA patients, and provide a valuable reference for clinical nursing of EGPA patients.展开更多
文摘目的:本研究旨在评估嗜酸性粒细胞增多性肺疾病(EGPA)患者的护理需求,并探讨个性化护理计划在改善患者肺功能、神经功能和生活质量方面的有效性。方法:2023年6月至2024年8月,采用随机数表法选取70名EGPA患者,随机分为观察组和对照组,每组35名。观察组实施个性化护理计划,包括多学科团队合作、药物管理、心理支持和健康教育等。对照组接受标准护理。对两组患者的肺功能(FEV1、FVC)、神经功能(NIHSS评分)和生活质量(SGRQ评分)进行评估。结果:观察组在干预后的FEV1、FVC、NIHSS评分和SGRQ评分均有显著改善,与对照组相比差异具有统计学意义(P Objective: This study was designed to assess the care needs of patients with eosinophilic lung disease (EGPA) and to explore the effectiveness of personalized care plans in improving lung function, neurological function, and quality of life in patients. Methods: From June 2023 to August 2024, 70 EGPA patients were selected by random number table method and randomly divided into observation group and control group, with 35 patients in each group. The observation group implemented individualized care plan, including multidisciplinary teamwork, medication management, psychological support and health education. The control group received standard care. Pulmonary function (FEV1, FVC), neurological function (NIHSS score), and quality of life (SGRQ score) were evaluated in both groups. Results: FEV1, FVC, NIHSS and SGRQ scores in the observation group were significantly improved after intervention, and the difference was statistically significant compared with the control group (P < 0.05). Conclusion: Personalized nursing plan can effectively improve lung function, neurological function and quality of life of EGPA patients, and provide a valuable reference for clinical nursing of EGPA patients.
